Allakos Inc. announced the appointment of Natalie Holles, president and chief executive officer of Audentes Therapeutics, to the Allakos board of directors. She is currently the President and Chief Executive Officer of Audentes Therapeutics (acquired by Astellas Pharma in 2020) which she joined in 2015 as Chief Operating Officer. Prior to joining Audentes, she served as senior vice president, corporate development at Hyperion Therapeutics (acquired by Horizon Pharma in 2015). She is a member of the Board of Directors for Rubius Therapeutics.